Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Isoflurane
Animalcare Limited
QN01AB06
Isoflurane
1000 milligram(s)/gram
Inhalation vapour, liquid
VPO: Veterinary Practitioner Only as defined in relevant national legislation
Cats, Dogs, Ferrets, Gerbils, Guinea pigs, Hamsters, Horses, Other Birds, Reptiles
isoflurane
Neurological Preparations
Authorised
2016-08-16
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Isocare 1000 mg/g Inhalation Vapour, Liquid 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each g contains: Isoflurane 1000 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Inhalation Vapour, Liquid Clear, colourless, volatile, liquid 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses, dogs, cats, ornamental birds, reptiles, rats, mice, hamsters, chinchillas, gerbils, guinea pigs and ferrets. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Induction and maintenance of general anaesthesia. 4.3 CONTRAINDICATIONS Do not use in cases of known susceptibility to malignant hyperthermia. Do not use in cases of known hypersensitivity to the active substance. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES The metabolism of birds, and to an extent small mammals, is affected more profoundly by decreases in body temperature, due to high surface area to body weight ratio. Drug metabolism in reptiles is slow and highly dependent upon environmental temperature. The ease and rapidity of alteration of the depth of anaesthesia with isoflurane and its low metabolism may be considered advantageous for its use in special groups of patients such as old or young, and those with impaired hepatic, renal or cardiac function. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _0_ _5_ _/_ _0_ _9_ _/_ _2_ _0_ _1_ _6_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _4_ _6_ _6_ _8_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _ Read the complete document